NOLAN: Naproxen or Loratadine and Neulasta

Clinical trial NCT01712009 · COMPLETED

Trial details

NCT number: NCT01712009
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bone Pain in Stage I - III Breast Cancer

Start date: 2012-11-01
Primary completion: 2015-03-18
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.